Recent Finacing
Recent Raise
Synklino is a Copenhagen biotech spinout developing SYN002 to target lytic and latent cytomegalovirus in transplant patients, advancing ex vivo and in vivo Phase 1 clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Synklino.
